Google Broadens Diabetes Reach With Dexcom Partnership
This article was originally published in Clinica
Executive Summary
DexCom Inc. is partnering with Google Inc. to develop smaller and cheaper continuous glucose meters (CGM) that would broaden their target market from a current focus on type 1 diabetes patients to the broader population. The partnership also may include using Google's cloud servers to collect and analyze glucose-meter data from patients to improve outcomes and reduce healthcare costs.
You may also be interested in...
New GSK-Verily JV Aims For Smart, 'Grain Of Rice' Neuromod Tech
Galvani Bioelectronics, the new joint venture between Google’s health-care spinoff Verily and drug giant GSK, will develop a new generation of "bioelectronic medicines" – neuromodulating therapies to treat a wide range of chronic diseases. Brian Otis, CTO of Verily, tells Medtech Insight how the devices that will come out of Galvani differ from existing neuromodulation technologies.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.